Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
56
ALAB Quote, Financials, Valuation and Earnings
Last price:
$90.70
Seasonality move
:
-40.27%
Day range:
$87.29 - $94.79
52-week range:
$36.22 - $147.39
Dividend yield:
0%
P/E ratio:
412.36x
P/S ratio:
30.07x
P/B ratio:
14.36x
Volume:
11.1M
Avg. volume:
4.1M
1-year change:
38.63%
Market cap:
$15B
Revenue:
$396.3M
EPS (TTM):
$0.22
Analysts' Opinion
-
Consensus RatingAstera Labs has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $101.87, Astera Labs has an estimated upside of 12.3% from its current price of $90.72.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $75.00 representing 100% downside risk from its current price of $90.72.
Fair Value
-
According to the consensus of 10 analysts, Astera Labs has 12.3% upside to fair value with a price target of $101.87 per share.
ALAB vs. S&P 500
-
Over the past 5 trading days, Astera Labs has underperformed the S&P 500 by -5.58% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Astera Labs does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Astera Labs has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Astera Labs reported revenues of $159.4M.
Earnings Growth
-
Astera Labs has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Astera Labs reported earnings per share of $0.18.
Enterprise value:
14B
EV / Invested capital:
13.48x
Price / LTM sales:
30.07x
EV / EBIT:
--
EV / Revenue:
28.62x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
129.77x
Price / Operating cash flow:
136.34x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$371.6M
Return On Assets:
4.19%
Net Income Margin (TTM):
8.44%
Return On Equity:
4.55%
Return On Invested Capital:
4.55%
Operating Margin:
7.08%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | $163.4M | $490.5M | $65.3M | $159.4M | |
| Gross Profit | -- | $126.1M | $371.6M | $50.5M | $119.4M | |
| Operating Income | -- | -$93.5M | -$21.8M | -$83M | $11.3M | |
| EBITDA | -- | -$91.5M | -$18.1M | -$82.4M | $12.4M | |
| Diluted EPS | -- | -$1.85 | $0.22 | -$1.77 | $0.18 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $854.4M | $1.1B | |
| Total Assets | -- | -- | -- | $864.9M | $1.1B | |
| Current Liabilities | -- | -- | -- | $45.6M | $77.3M | |
| Total Liabilities | -- | -- | -- | $56.1M | $80.1M | |
| Total Equity | -- | -- | -- | $808.8M | $1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$5.2M | $143.5M | $3.7M | $10.5M | |
| Cash From Investing | -- | -$57.3M | -$757.3M | -$4.3M | -$3.9M | |
| Cash From Financing | -- | $651M | $4.6M | $651.6M | $386K | |
| Free Cash Flow | -- | -$11M | $108.2M | $228K | $6M | |
ALAB
Sector
Market Cap
$15B
$79.6M
Price % of 52-Week High
61.55%
61.26%
Dividend Yield
0%
0%
Shareholder Yield
0.01%
0.79%
1-Year Price Total Return
38.63%
-14.63%
Beta (5-Year)
--
0.829
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$94.61
200-day SMA
Buy
Level
$80.54
Bollinger Bands (100)
Buy
Level
60.79 - 105.67
Chaikin Money Flow
Buy
Level
68.6M
20-day SMA
Buy
Level
$85.87
Relative Strength Index (RSI14)
Buy
Level
61.32
ADX Line
Buy
Level
31.62
Williams %R
Neutral
Level
-40.0251
50-day SMA
Buy
Level
$71.69
MACD (12, 26)
Buy
Level
7.23
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
89.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (144.3156)
Buy
CA Score
(Annual)
Level (-0.166)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.5472)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.
Stock Forecast FAQ
In the current month, ALAB has received 9 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ALAB average analyst price target in the past 3 months is $101.87.
-
Where Will Astera Labs Stock Be In 1 Year?
According to analysts, the consensus estimate is that Astera Labs share price will rise to $101.87 per share over the next 12 months.
-
What Do Analysts Say About Astera Labs?
Analysts are divided on their view about Astera Labs share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Astera Labs is a Sell and believe this share price will drop from its current level to $75.00.
-
What Is Astera Labs's Price Target?
The price target for Astera Labs over the next 1-year time period is forecast to be $101.87 according to 10 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ALAB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Astera Labs is a Buy. 9 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ALAB?
You can purchase shares of Astera Labs via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Astera Labs shares.
-
What Is The Astera Labs Share Price Today?
Astera Labs was last trading at $90.70 per share. This represents the most recent stock quote for Astera Labs. Yesterday, Astera Labs closed at $90.72 per share.
-
How To Buy Astera Labs Stock Online?
In order to purchase Astera Labs stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
